Rubius Therapeutics Current Ratio 2011-2026 | RUBY

Annual Current Ratio Rubius Therapeutics

2022	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011
2.91	2.28	2.04	8.57	20.7	14.7	2.41	-	-	-	-	-

All numbers in USD currency

Indicator range from annual reports

Maximum	Minimum	Average
20.7	2.04	7.66

Quarterly Current Ratio Rubius Therapeutics

2022-Q4	2022-Q3	2022-Q2	2022-Q1	2021-Q4	2021-Q3	2021-Q2	2021-Q1	2020-Q4	2020-Q3	2020-Q2	2020-Q1	2019-Q4	2019-Q3	2019-Q2	2019-Q1	2018-Q4	2018-Q3	2018-Q2	2018-Q1	2017-Q4	2017-Q3	2017-Q2	2017-Q1	2016-Q4	2016-Q3	2016-Q2	2016-Q1	2015-Q4	2015-Q3	2015-Q2	2015-Q1	2014-Q4	2014-Q3	2014-Q2	2014-Q1	2013-Q4	2013-Q3	2013-Q2	2013-Q1	2012-Q4	2012-Q3	2012-Q2	2012-Q1	2011-Q4	2011-Q3	2011-Q2	2011-Q1
-	1.27	1.72	2.02	2.28	2.64	3	3.33	2.04	2.04	2.04	2.04	3.27	3.27	3.27	3.27	5.56	5.56	5.56	5.56	9.3	9.3	9.3	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-

All numbers in USD currency

Indicator range from quarterly reporting

Maximum	Minimum	Average
9.3	1.27	3.98

Current Ratio of other stocks in the Biotechnology industry

Issuer	Current Ratio	Price	% 24h	Market Cap	Country
MorphoSys AG MOR	1.02	-	2.43 %	$ 254 M	Germany
ARCA biopharma ABIO	28.7	-	1052.0 %	$ 415 M	USA
Amarin Corporation plc AMRN	3.17	$ 14.67	-	$ 6.09 B	Irlanda
Aeterna Zentaris AEZS	1.6	-	5.93 %	$ 314 M	Canada
AgeX Therapeutics AGE	0.995	-	-10.17 %	$ 12.2 K	USA
Aeglea BioTherapeutics AGLE	12.4	-	-	$ 1.01 B	USA
AIkido Pharma AIKI	6.48	-	1.93 %	$ 17.4 M	USA
Akouos AKUS	6.18	-	0.23 %	$ 488 M	USA
Akero Therapeutics AKRO	10.9	-	-	$ 3.67 B	USA
I-Mab IMAB	8.96	-	-	$ 866 M	China
Alexion Pharmaceuticals, Inc. ALXN	3.59	-	-	$ 40.3 B	USA
Genfit SA GNFT	0.922	-	2.54 %	$ 160 B	France
Albireo Pharma ALBO	2.39	-	-0.23 %	$ 916 M	USA
Biophytis SA BPTS	1.34	-	-13.47 %	$ 169 M	France
Cabaletta Bio CABA	3.11	$ 2.82	-	$ 283 M	USA
Aileron Therapeutics ALRN	3.34	-	10.36 %	$ 9.8 M	USA
Aptinyx APTX	2.35	-	-39.0 %	$ 4.57 M	USA
Midatech Pharma plc MTP	2.29	-	-18.52 %	$ 27.3 M	Britain
EyeGate Pharmaceuticals, Inc. EYEG	1.02	-	-1.52 %	$ 24.7 M	USA
Arena Pharmaceuticals ARNA	10.8	-	-6.81 %	$ 3.04 B	USA
CollPlant Biotechnologies Ltd. CLGN	3.57	$ 0.66	-0.45 %	$ 7.56 M	Israel
Applied Genetic Technologies Corporation AGTC	1.79	-	-	$ 26.5 M	USA
Avenue Therapeutics ATXI	3.27	-	-52.27 %	$ 4.45 M	USA
Ayala Pharmaceuticals AYLA	6.43	-	-	$ 7.46 M	Israel
CEL-SCI Corporation CVM	1.91	$ 3.47	-	$ 221 M	USA
Atreca BCEL	2.02	-	-11.76 %	$ 5.79 M	USA
Acorda Therapeutics ACOR	1.61	-	-24.86 %	$ 820 K	USA
bluebird bio BLUE	1.46	-	-	$ 546 M	USA
Denali Therapeutics DNLI	9.51	$ 19.74	-	$ 3.25 B	USA
Acasti Pharma ACST	13.4	-	4.01 %	$ 150 M	Canada
Институт стволовых клеток человека ISKJ	1.04	-	-	-	Russia
Avid Bioservices CDMO	1.22	-	-	$ 789 M	USA
Adverum Biotechnologies ADVM	1.65	-	-	$ 86.2 M	USA
Acer Therapeutics ACER	0.41	-	2.71 %	$ 14 M	USA
Advaxis ADXS	5.93	-	-9.65 %	$ 45.9 M	USA
Autolus Therapeutics plc AUTL	2.2	$ 1.29	-	$ 329 M	Britain
Esperion Therapeutics ESPR	0.607	$ 2.85	-	$ 592 M	USA
EyePoint Pharmaceuticals EYPT	6.29	$ 13.06	-	$ 957 K	USA
BeiGene, Ltd. BGNE	2.14	-	0.49 %	$ 251 B	Cayman-islands
BioDelivery Sciences International BDSI	2.37	-	-4.8 %	$ 255 M	USA
Cara Therapeutics CARA	1.83	-	-3.03 %	$ 260 M	USA
ChemoCentryx CCXI	3.05	-	-	$ 3.74 B	USA
Enlivex Therapeutics Ltd. ENLV	6.76	$ 1.09	-	$ 22.4 M	Israel
Enochian Biosciences ENOB	0.278	-	-	$ 40.5 M	USA
CureVac N.V. CVAC	2.47	-	-	$ 867 M	Germany
Equillium EQ	9.69	$ 2.06	-	$ 118 M	USA
Eton Pharmaceuticals ETON	1.4	$ 23.45	-	$ 631 M	USA
Bellerophon Therapeutics BLPH	1.47	-	-74.18 %	$ 955 K	USA
CRISPR Therapeutics AG CRSP	6.6	$ 47.55	-	$ 4.28 B	Schweiz
Arbutus Biopharma Corporation ABUS	5.24	$ 4.45	-	$ 853 M	Canada